Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2019Science Translational MedicineOpen Access

MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAnna E. VilgelmThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNSNabil SalehAin Shams UniversityRSRebecca L. Shattuck-BrandtVanderbilt University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vilgelm et al. (2019) studied this question.

synapsesocial.com/papers/6a98f56abd3522584418efd3https://doi.org/10.1126/scitranslmed.aav7171
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response2018 · 134 citations
  2. 2Multiple faces of FoxM1 transcription factor2011 · 211 citations
  3. 3Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway2020 · 38 citations
  4. 4In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)2002 · 367 citations
  5. 5Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells2018 · 75 citations